Current role
Derrick C. Li
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Derrick C. Li
Aardvark Therapeutics, Inc. reported in an 8-K filed February 12, 2026 that Derrick C. Li was appointed Chief Business Officer, effective February 9, 2026.
“On February 12, 2026, the Company issued a press release announcing the appointment of Derrick C. Li as the Company’s Chief Business Officer, as well as the expansion of Mr. Sun’s role to include Chief Operating Officer, in addition to his current role as the Company’s Chief Financial Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-02-09–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aardvark Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Tien-Li Lee CEO, Board Member
- Nelson Sun CFO, COO
- David (Zhongwei) Zhang Board Member
- Jeffrey Chi Board Member
- Roy D. Baynes Board Member
- Susan E. Graf Board Member
- Victor Tong Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.